Literature DB >> 18345527

[Substitution of thyroid hormones].

R Gärtner1, M Reincke.   

Abstract

In patients with overt hypothyroidism the substitution with Levothyroxine is mandatory, whereas in patients with subclinical hypothyroidism it is dependent on further clinical signs and symptoms. The main parameter indicating sufficient substitution of Levothyroxine in patients with primary hypothyroidism is TSH, whereas in secondary hypothyroidism it is free T(4). At present Levothyroxine is the preparation of choice to restore euthyroidism in hypothyroid patients because it is assumed that the peripheral conversion from T(4) to T(3) provides the exact amount of T(3) needed by every organ. Intestinal absorption of Levothyroxin is around 80%, but only in acid environment and is significantly decreased by proton-pump inhibitors, antacids, atrophic gastritis and Helicobacter pylori infection. The usual required dosage of Levothyroxine is 1.5 microg/kg of body weight but is increased under these conditions as well as during early childhood and pregnancy, and is decreased in older people. The bioavailability of different Levothyroxin generics might change between 0.8 and 1.25. Therefore, the thyroid function of patients, receiving another brand of Levothyroxine has to be re-checked.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18345527     DOI: 10.1007/s00108-008-2109-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  21 in total

Review 1.  Thyroid-hormone therapy and thyroid cancer: a reassessment.

Authors:  Bernadette Biondi; Sebastiano Filetti; Martin Schlumberger
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2005-11

Review 2.  REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine.

Authors:  Héctor F Escobar-Morreale; José I Botella-Carretero; Francisco Escobar del Rey; Gabriella Morreale de Escobar
Journal:  J Clin Endocrinol Metab       Date:  2005-05-31       Impact factor: 5.958

3.  Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.

Authors:  E Ferretti; L Persani; M L Jaffrain-Rea; S Giambona; G Tamburrano; P Beck-Peccoz
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

4.  The Colorado thyroid disease prevalence study.

Authors:  G J Canaris; N R Manowitz; G Mayor; E C Ridgway
Journal:  Arch Intern Med       Date:  2000-02-28

Review 5.  Myxedema coma.

Authors:  Leonard Wartofsky
Journal:  Endocrinol Metab Clin North Am       Date:  2006-12       Impact factor: 4.741

6.  Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.

Authors:  J J Staub; B U Althaus; H Engler; A S Ryff; P Trabucco; K Marquardt; D Burckhardt; J Girard; B D Weintraub
Journal:  Am J Med       Date:  1992-06       Impact factor: 4.965

7.  TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).

Authors:  C Meier; J J Staub; C B Roth; M Guglielmetti; M Kunz; A R Miserez; J Drewe; P Huber; R Herzog; B Müller
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

8.  Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism.

Authors:  Erik K Alexander; Ellen Marqusee; Jennifer Lawrence; Petr Jarolim; George A Fischer; P Reed Larsen
Journal:  N Engl J Med       Date:  2004-07-15       Impact factor: 91.245

9.  Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism.

Authors:  R Bunevicius; G Kazanavicius; R Zalinkevicius; A J Prange
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

10.  L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies.

Authors:  Serenella Checchi; Annalisa Montanaro; Letizia Pasqui; Cristina Ciuoli; Valentina De Palo; Maria Celeste Chiappetta; Furio Pacini
Journal:  J Clin Endocrinol Metab       Date:  2007-11-27       Impact factor: 5.958

View more
  5 in total

Review 1.  Hormone replacement after thyroid and parathyroid surgery.

Authors:  Andreas Schäffler
Journal:  Dtsch Arztebl Int       Date:  2010-11-26       Impact factor: 5.594

Review 2.  [Substitution with thyroid hormones in the elderly : Goals and risks].

Authors:  A von Werder; K von Werder
Journal:  Internist (Berl)       Date:  2018-10       Impact factor: 0.743

3.  Impairment of Health-related Quality of Life among Indian Patients with Hypothyroidism.

Authors:  C Shivaprasad; Boppana Rakesh; Kolly Anish; Pullikal Annie; Goel Amit; C S Dwarakanath
Journal:  Indian J Endocrinol Metab       Date:  2018 May-Jun

4.  Determining the Association Between Helicobacter pylori Infection and Treatment-Refractory Hypothyroidism.

Authors:  Muhammad Zahid Z Jamil; Sadia Salman; Mehwish Akhtar; Sadaf Iqbal; Amanullah Bhalli; Hasan Farooq
Journal:  Cureus       Date:  2022-01-17

5.  Patient-reported outcomes in adequately treated hypothyroidism - insights from the German versions of ThyDQoL, ThySRQ and ThyTSQ.

Authors:  Eva M Quinque; Arno Villringer; Juergen Kratzsch; Stefan Karger
Journal:  Health Qual Life Outcomes       Date:  2013-04-23       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.